Sandeep Arora, MBBS
Associate Professor of Radiology and Biomedical ImagingCards
About
Research
Publications
2024
MRI after focal therapy for prostate cancer: what radiologists must know?
Jalilianhasanpour R, Arora S, Mansoori B, Raman S, Greenwood B, Sprenkle P, Schade G, Camacho M, Hosseini N, Westphalen A. MRI after focal therapy for prostate cancer: what radiologists must know? Abdominal Radiology 2024, 1-20. PMID: 39542951, DOI: 10.1007/s00261-024-04670-5.Peer-Reviewed Original Research
2023
MR Imaging-Guided Prostate Cancer Therapies
Adamo D, Greenwood B, Ghanouni P, Arora S. MR Imaging-Guided Prostate Cancer Therapies. Radiologic Clinics Of North America 2023, 62: 121-133. PMID: 37973238, DOI: 10.1016/j.rcl.2023.06.012.Peer-Reviewed Original ResearchConceptsProstate cancerTransrectal high-intensity focused ultrasoundLong-term oncologic dataIntermediate-risk prostate cancerTreatment of prostate cancerWhole-gland therapyTransurethral ultrasound ablationRadical prostatectomyHigh-intensity focused ultrasoundRadiation therapyImaging-guided therapyTherapeutic optionsOncological dataUltrasound ablationCancerTherapyProstateTreatmentAblationMenProstatectomyCryoablationMalignancyUltrasoundMRI of Benign Prostatic Hyperplasia: Important Pre- and Posttherapeutic Considerations.
Han E, Nandalur K, Morgan M, Arora S, Loening A, Bivalacqua T, Sundaram K. MRI of Benign Prostatic Hyperplasia: Important Pre- and Posttherapeutic Considerations. RadioGraphics 2023, 43: e220096. PMID: 37022958, DOI: 10.1148/rg.220096.Peer-Reviewed Original ResearchConceptsLower urinary tract symptomsTransurethral resection of the prostateBenign prostatic hypertrophyDetection of clinically significant prostate cancerClinically significant prostate cancerSignificant prostate cancerProstatic artery embolizationProstate cancerProstate MRIArtery embolizationImprove lower urinary tract symptomsBenign prostatic hypertrophy treatmentInterpretation of prostate MRIWater vapor thermal therapyEvaluation of lower urinary tract symptomsTreatment of benign prostatic hypertrophyPeriurethral prostatic tissuePrebiopsy prostate MRIPredictors of treatment successProstatic urethral liftUrinary tract symptomsMinimally invasive techniquesMinimally invasive treatmentPostprocedural MRILaser enucleationA0964 Four-year follow-up of MRI-guided Transurethral Ultrasound Ablation (TULSA) in men with localized prostate cancer
Klotz L, Chin J, Futterer J, Hatiboglu G, Pavlovich C, Koch M, Penson D, Relle J, Raman S, Lotan Y, Serrallach M, Heidenreich A, Oto A, Sedelaar J, Tirkes T, Arora S, Macura K, Costa D, Pantuck A, Bomers J, Bonekamp D, Persigehl T, Clarke G, Eggener S. A0964 Four-year follow-up of MRI-guided Transurethral Ultrasound Ablation (TULSA) in men with localized prostate cancer. European Urology 2023, 83: s1381-s1382. DOI: 10.1016/s0302-2838(23)01004-7.Peer-Reviewed Original Research
2022
Therapeutic US Applications for the Abdomen and Pelvis.
Sailer A, Ghanouni P, Schade G, Napoli A, Vidal-Jove J, Raman S, Mendiratta-Lala M, Ghai S, Abreu A, Sundaram K, Westphalen A, Arora S. Therapeutic US Applications for the Abdomen and Pelvis. RadioGraphics 2022, 42: e182-e183. PMID: 36190852, PMCID: PMC9539095, DOI: 10.1148/rg.220044.Peer-Reviewed Original ResearchRadiologists staunchly support patient safety and autonomy, in opposition to the SCOTUS draft.
Andreotti RF, Arleo EK, Arora SS, Broder JC, Brook O, Cooke EA, Davis MA, Dodelzon K, Englander MJ, Fischbein NJ, Fleischer A, Frederick-Dyer K, Gerson RF, Gruen D, Hecht EM, Katzen JT, Kemp J, Kotsenas AL, Ladd LM, Malik A, McGinty G, Meltzer CC, Oliveira A, Phillips C, Porter KK, Rhyner P, Robson C, Shatzkes D, Spalluto LB, Sun M, Tomblinson C, Vincoff NS, Wood MJ, Zigmund B, Glastonbury C, Ivanidze J, Schwartz ES, Woodard PK. Radiologists staunchly support patient safety and autonomy, in opposition to the SCOTUS draft. Clinical Imaging 2022, 89: 95-96. PMID: 35772335, DOI: 10.1016/j.clinimag.2022.05.012.Peer-Reviewed Original ResearchRadiologists staunchly support patient safety and autonomy, in opposition to the SCOTUS decision to overturn Roe v Wade
Karandikar A, Solberg A, Fung A, Lee AY, Farooq A, Taylor AC, Oliveira A, Narayan A, Senter A, Majid A, Tong A, McGrath AL, Malik A, Brown AL, Roberts A, Fleischer A, Vettiyil B, Zigmund B, Park B, Curran B, Henry C, Jaimes C, Connolly C, Robson C, Meltzer CC, Phillips CH, Dove C, Glastonbury C, Pomeranz C, Kirsch CFE, Burgan CM, Scher C, Tomblinson C, Fuss C, Santillan C, Daye D, Brown DB, Young DJ, Kopans D, Vargas D, Martin D, Thompson D, Jordan DW, Shatzkes D, Sun D, Mastrodicasa D, Smith E, Korngold E, Dibble EH, Arleo EK, Hecht EM, Morris E, Maltin EP, Cooke EA, Schwartz ES, Lehrman E, Sodagari F, Shah F, Doo FX, Rigiroli F, Vilanilam GK, Landinez G, Kim GG, Rahbar H, Choi H, Bandesha H, Ojeda-Fournier H, Ikuta I, Dragojevic I, Schroeder JLT, Ivanidze J, Katzen JT, Chiang J, Nguyen J, Robinson JD, Broder JC, Kemp J, Weaver JS, Conyers JM, Robbins JB, Leschied JR, Wen J, Park J, Mongan J, Perchik J, Barbero JPM, Jacob J, Ledbetter K, Macura KJ, Maturen KE, Frederick-Dyer K, Dodelzon K, Cort K, Kisling K, Babagbemi K, McGill KC, Chang KJ, Feigin K, Winsor KS, Seifert K, Patel K, Porter KK, Foley KM, Patel-Lippmann K, McIntosh LJ, Padilla L, Groner L, Harry LM, Ladd LM, Wang L, Spalluto LB, Mahesh M, Marx MV, Sugi MD, Sammer MBK, Sun M, Barkovich MJ, Miller MJ, Vella M, Davis MA, Englander MJ, Durst M, Oumano M, Wood MJ, McBee MP, Fischbein NJ, Kovalchuk N, Lall N, Eclov N, Madhuripan N, Ariaratnam NS, Vincoff NS, Kothary N, Yahyavi-Firouz-Abadi N, Brook OR, Glenn OA, Woodard PK, Mazaheri P, Rhyner P, Eby PR, Raghu P, Gerson RF, Patel R, Gutierrez RL, Gebhard R, Andreotti RF, Masum R, Woods R, Mandava S, Harrington SG, Parikh S, Chu S, Arora SS, Meyers SM, Prabhu S, Shams S, Pittman S, Patel SN, Payne S, Hetts SW, Hijaz TA, Chapman T, Loehfelm TW, Juang T, Clark TJ, Potigailo V, Shah V, Planz V, Kalia V, DeMartini W, Dillon WP, Gupta Y, Koethe Y, Hartley-Blossom Z, Wang ZJ, McGinty G, Haramati A, Allen LM, Germaine P. Radiologists staunchly support patient safety and autonomy, in opposition to the SCOTUS decision to overturn Roe v Wade. Clinical Imaging 2022, 93: 117-121. PMID: 36064645, DOI: 10.1016/j.clinimag.2022.07.011.Peer-Reviewed Original ResearchReal-Time MRI-Guided Prostate Interventions
Masoom SN, Sundaram KM, Ghanouni P, Fütterer J, Oto A, Ayyagari R, Sprenkle P, Weinreb J, Arora S. Real-Time MRI-Guided Prostate Interventions. Cancers 2022, 14: 1860. PMID: 35454773, PMCID: PMC9030365, DOI: 10.3390/cancers14081860.Peer-Reviewed Original Research
2021
Imaging Features at the Periphery: Hemodynamics, Pathophysiology, and Effect on LI-RADS Categorization.
Consul N, Sirlin CB, Chernyak V, Fetzer DT, Masch WR, Arora SS, Do RKG, Marks RM, Fowler KJ, Borhani AA, Elsayes KM. Imaging Features at the Periphery: Hemodynamics, Pathophysiology, and Effect on LI-RADS Categorization. RadioGraphics 2021, 41: 1657-1675. PMID: 34559586, DOI: 10.1148/rg.2021210019.Peer-Reviewed Original ResearchConceptsHepatocellular carcinomaEnhancement patternLiver observationsCapsule appearanceRim arterial phase hyperenhancementAncillary featuresNon-HCC malignanciesLocal-regional therapyArterial phase hyperenhancementLiver Imaging ReportingDynamic contrast-enhanced imagingDifferent enhancement patternsImaging-based diagnosisContrast-enhanced imagingPeripheral washoutArterioportal shuntTargetoid appearanceNodular enhancementCorona enhancementBenign entityTreatment responseLI-RADSRisk populationsLiver lesionsSpecific diagnosisMP46-03 PIVOTAL TRIAL OF MRI-GUIDED TRANSURETHRAL ULTRASOUND ABLATION IN MEN WITH LOCALIZED PROSTATE CANCER: THREE-YEAR FOLLOW-UP
Klotz L, Pavlovich C, Chin J, Hatiboglu G, Koch M, Penson D, Raman S, Oto A, Fütterer J, Serrallach M, Relle J, Lotan Y, Heidenreich A, Bonekamp D, Haider M, Sedelaar J, Tirkes T, Arora S, Macura K, Costa D, Pantuck A, Bomers J, Clarke G, Staruch R, Eggener S. MP46-03 PIVOTAL TRIAL OF MRI-GUIDED TRANSURETHRAL ULTRASOUND ABLATION IN MEN WITH LOCALIZED PROSTATE CANCER: THREE-YEAR FOLLOW-UP. Journal Of Urology 2021, 206: e814-e814. DOI: 10.1097/ju.0000000000002067.03.Peer-Reviewed Original Research
Clinical Trials
Current Trials
The HistoSonics Edison System for Treatment of Primary Solid Renal Tumors Using Histotripsy (#HOPE4KIDNEY US)
HIC ID2000035349RoleSub InvestigatorPrimary Completion Date12/31/2024Recruiting ParticipantsGenderBothAge22+ yearsCustomized Ablation of the Prostate With the TULSA Procedure Against Radical Prostatectomy Treatment: a Randomized Controlled Trial for Localized Prostate Cancer (CAPTAIN)
HIC ID2000030487RolePrincipal InvestigatorPrimary Completion Date12/01/2023Recruiting Participants
Clinical Care
Overview
Sandeep Arora, MBBS (a medical degree awarded outside the U.S.), is a radiologist who specializes in using imaging techniques to diagnose and manage a wide range of conditions. He works with patients to interpret images from ultrasound, CT scans, and MRI, helping provide clear assessments that guide treatment options.
As an associate professor of radiology and biomedical imaging at Yale School of Medicine, Dr. Arora investigates ways to refine noninvasive imaging of the abdominal and pelvic areas. He focuses on improving diagnostic accuracy so that physicians can create more effective treatment plans.
Dr. Arora received his medical training at University College of Medical Sciences in Delhi, India He then completed an internship in surgery at University of California, Davis Medical Center, followed by a residency in radiology at the University of Louisville and a fellowship in radiology and biomedical imaging at the University of California, San Francisco.
Clinical Specialties
Radiology & Biomedical Imaging
News
News
- February 28, 2024
TULSA #50: Marking a Milestone
- January 19, 2024
Leading Gastrointestinal and Genitourinary Cancer Conferences to Feature Yale Cancer Center Researchers
- June 22, 2023
Profiles in Survivorship: Stephan Brigidi
- August 19, 2021
First TULSA Procedure Performed at Yale New Haven Hospital
Get In Touch
Contacts
Academic Office Number